Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Liver Impairment”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Early research (Phase 1)Study completedNCT02120547
What this trial is testing

Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment

Who this might be right for
Liver Insufficiency
Tobira Therapeutics, Inc. 31
Early research (Phase 1)Study completedNCT04406896
What this trial is testing

The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics

Who this might be right for
Healthy SubjectsHepatic Impairment
Viatris Innovation GmbH 24
Early research (Phase 1)Study completedNCT06336018
What this trial is testing

A Research Study on Etavopivat in Participants With and Without Liver Disease

Who this might be right for
Liver Diseases
Novo Nordisk A/S 48
Early research (Phase 1)Study completedNCT01298063
What this trial is testing

Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 35
Early research (Phase 1)UnknownNCT04631549
What this trial is testing

An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy Participants

Who this might be right for
Hepatic ImpairmentHealthy Participants
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT03842761
What this trial is testing

Test How Different Doses of BI 685509 Are Tolerated in Patients With Liver Problems

Who this might be right for
HealthyHepatic Insufficiency
Boehringer Ingelheim 64
Early research (Phase 1)Study completedNCT05731908
What this trial is testing

Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 28
Early research (Phase 1)Study completedNCT01860326
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects

Who this might be right for
Hepatic Insufficiency
Debiopharm International SA 32
Early research (Phase 1)Study completedNCT06888115
What this trial is testing

The Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

Who this might be right for
Primary Biliary Cholangitis
Cascade Pharmaceuticals, Inc 24
Post-approval studies (Phase 4)Study completedNCT03778567
What this trial is testing

Renoprotective Effects of Telbivudine in Chronic Hepatitis B

Who this might be right for
Hepatitis B, ChronicChronic Kidney Diseases
The University of Hong Kong 31
Early research (Phase 1)Study completedNCT06425198
What this trial is testing

Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Participants
Bristol-Myers Squibb 37
Early research (Phase 1)Study completedNCT04634149
What this trial is testing

Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Who this might be right for
Moderate Liver ImpairmentSevere Liver Impairment
Bristol-Myers Squibb 16
Early research (Phase 1)Study completedNCT02108639
What this trial is testing

To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 41
Early research (Phase 1)Looking for participantsNCT07401862
What this trial is testing

Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.

Who this might be right for
Hepatic Insufficiency
Eli Lilly and Company 36
Early research (Phase 1)Study completedNCT02161224
What this trial is testing

Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function

Who this might be right for
PK of FG-4592Hepatic InsufficiencyHealthy Subjects
Astellas Pharma Europe B.V. 16
Early research (Phase 1)Study completedNCT01529294
What this trial is testing

Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 90
Early research (Phase 1)Study completedNCT04552808
What this trial is testing

To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects

Who this might be right for
Hepatic Impairment
Sunshine Lake Pharma Co., Ltd. 16
Early research (Phase 1)Ended earlyNCT03295266
What this trial is testing

Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006)

Who this might be right for
Hepatic InsufficiencyAntibacterial Agents
Merck Sharp & Dohme LLC 9
Early research (Phase 1)Looking for participantsNCT07165002
What this trial is testing

The Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 32
Early research (Phase 1)Study completedNCT05835180
What this trial is testing

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Who this might be right for
Non-alcoholic SteatohepatitisHepatic ImpairmentCirrhosis
Sagimet Biosciences Inc. 48
Load More Results